Fintel reports that on October 3, 2025, D. Boral Capital maintained coverage of UroGen Pharma (NasdaqGM:URGN) with a Buy ...
Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Among the demands that ...
The pharmaceutical industry has immense pressure to deliver advanced and novel therapies to patients worldwide but faces monumental challenges in drug development. On average, the journey from ...